Inventory

9 Months Ended

Sep. 30, 2020

The Company evaluates expiry risk by evaluating current and future product demand relative to product shelf life. The Company builds demand forecasts by considering factors such as, but not limited to, overall market potential, market share, market acceptance and patient usage. Inventory levels are evaluated for the amount of inventory that would be sold within one year. At certain times, the level of inventory can exceed the forecasted level of cost of goods sold for the next twelve months. The Company classifies the estimate of such inventory as non-current.

Inventory consisted of the following as of September 30, 2020 and December 31, 2019:


(in thousands)	September 30, 2020		December 31, 2019
Current assets

Finished goods	$	1,322	$	1,140
Total inventory, current	$	1,322	$	1,140
Non-Current assets
Raw materials	$	745	$	659
Work-in-process	4,109		1,109
Finished goods	527		1,056
Total inventory, non-current	5,381		2,824
Total inventory	$	6,703	$	3,964